APVO
Aptevo Therapeutics·NASDAQ
--
--(--)
--
--(--)
APVO fundamentals
Aptevo Therapeutics (APVO) released its earnings on Aug 11, 2025: revenue was 0 (YoY --), met estimates; EPS was -151.2 (YoY +99.32%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-151.2
+99.32%
Report date
Aug 11, 2025
EPS
Actual | -1793404.8 | -1230768 | -1260072 | -1060804.8 | -1019779.2 | -1043222.4 | -849816 | -761904 | -931867.2 | 3252942.095 | -898116.611 | -621244.8 | 152380.8 | -720878.4 | -293040 | -178887.6 | -132534 | -22244.4 | -6393.6 | -3218.4 | -1580.4 | -151.2 | ||||||
Forecast | -820512 | -1240536 | -1201464 | -908424 | -980707.2 | -1172160 | -838094.4 | -758973.6 | -673992 | -779486.4 | -955310.4 | -896702.4 | -694504.8 | -656409.6 | -375091.2 | -263736 | -143456.4 | -25707.6 | -7592.4 | -2790 | -1515.6 | -1497.6 | ||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -118.57% | +0.79% | -4.88% | -16.77% | -3.98% | +11.00% | -1.40% | -0.39% | -38.26% | +517.32% | +5.99% | +30.72% | +121.94% | -9.82% | +21.88% | +32.17% | +7.61% | +13.47% | +15.79% | -15.35% | -4.28% | +89.90% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | 0 | 473.00K | 1.50M | 2.37M | 2.42M | 3.11M | 3.10M | 3.66M | 3.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | 0 |
Forecast | -- | -- | -- | -- | -- | -- | 4.50M | 290.00K | 563.67K | 2.22M | 2.42M | 1.35M | 3.10M | 3.40M | 3.75M | 3.45M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | +63.10% | +166.11% | +7.08% | 0.00% | +130.37% | 0.00% | +7.71% | -16.96% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Aptevo Therapeutics's revenue and profit?What guidance did Aptevo Therapeutics's management provide for the next earnings period?What were the key takeaways from Aptevo Therapeutics’s earnings call?Did Aptevo Therapeutics beat or miss consensus estimates last quarter?What is Aptevo Therapeutics's latest dividend and current dividend yield?What is Aptevo Therapeutics's gross profit margin?What does Aptevo Therapeutics do and what are its main business segments?What were the key takeaways from Aptevo Therapeutics's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
